tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Wolleben, 118 are a BUY (99.16%), 1 are a HOLD (0.84%).
Analyst Jonathan Wolleben works at JMP with a stock forecast success ratio of 16.61% fulfilled within 126.06 days on average.
Jonathan Wolleben’s has documented 234 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 28-Mar-2024.
Analyst best performing recommendations are on PHVS (PHARVARIS BV).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) at 9/29/2020. The price target of $16 was fulfilled within 57 days with a profit of $8.19 (104.87%) receiving and performance score of 18.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
12
$3.39 (39.37%)
15
18 days ago
0/9 (0%)
$1.77 (17.30%)
Buy
20
$11.39 (132.29%)
20
22 days ago
4/14 (28.57%)
$9.82 (96.46%)
214
Hold
13
$4.39 (50.99%)
20
2 months 26 days ago
1/3 (33.33%)
$3.65 (39.04%)
34
Buy
16
$7.39 (85.83%)
15
4 months 18 days ago
0/12 (0%)
$12.43 (348.18%)
Buy
26
$17.39 (201.97%)
26
1 years 2 months 19 days ago
0/5 (0%)
$12.36 (90.62%)
Which stock is Jonathan Wolleben is most bullish on?
Which stock is Jonathan Wolleben is most reserved on?
What Year was the first public recommendation made by Jonathan Wolleben?
